Paradoxical Effect of Obesity on Survival Outcomes in Prostate Cancer Patients Receiving Enzalutamide and Abiraterone
<i>Background and Objectives</i>: Overweight and obesity is defined as a Body Mass Index (BMI) of 25.0–29.9 kg/m<sup>2</sup> and ≥30.0 kg/m<sup>2</sup>. The prognostic significance of obesity in metastatic prostate cancer is still unclear, especially between the castration-sensitive (CSPC) and castr...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
MDPI AG
2026-01-01
|
| Rangatū: | Medicina |
| Ngā marau: | |
| Urunga tuihono: | https://www.mdpi.com/1648-9144/62/1/202 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|